𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human papillomavirus status in young patients with head and neck squamous cell carcinoma

✍ Scribed by H.S. van Monsjou; M.L.F. van Velthuysen; M.W.M. van den Brekel; E.S. Jordanova; C.J.M. Melief; A.J.M. Balm


Publisher
John Wiley and Sons
Year
2011
Tongue
French
Weight
789 KB
Volume
130
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The role of human papillomavirus (HPV) in head and neck squamous cell carcinoma (HNSCC) development has been recognized only in the last decade. Although younger patients develop HNSCC associated with HPV, the incidence in young patients has not been studied. Forty‐five young HNSCC patients (<40 years) were tested for HPV and the expression of p16^ink4a^ and p53 in tumor biopsies. The presence of HPV was correlated with the absence and presence of alcohol and tobacco exposure. Paraffin‐embedded, archival biopsy materials from HNSCC of 45 patients younger than 40 years were analyzed. HPV subtypes were identified by PCR followed by genotyping. Expression of p16^ink4a^ and p53 were determined by immunohistochemistry. Fourteen (31%) of the HNSCC specimens from 45 patients unequivocally exhibited HPV16 positivity. Sixty percentage of the oropharyngeal tumors and 5% of the oral cavity tumors were HPV16 positive. P16^ink4a^ overexpression was detected in 93% of the HPV16‐positive tumors. None of the HPV16 tumors showed p53 overexpression. There was no association of HPV positivity with (lack of) exposure to alcohol and smoking. HPV association was not exclusively detected in nonsmoking, nondrinking young HNSCC patients. The presence of p16^ink4a^ accumulation and the absence of p53 overexpression are good surrogate markers for HPV‐associated HNSCC.


📜 SIMILAR VOLUMES


Human papillomavirus 16 and head and nec
✍ C. Sloane Furniss; Michael D. McClean; Judith F. Smith; Janine Bryan; Heather H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 2 views

## Abstract Evidence suggests that human papillomavirus (HPV)16 seropositivity reflects past HPV16 exposure and is associated with risk for head and neck squamous cell carcinoma (HNSCC). Our objectives were to test the hypothesis that HPV16 seropositivity is associated with risk for HNSCC, to corre

Prevalence and physical status of human
✍ Walter J. Koskinen; Ren Wei Chen; Ilmo Leivo; Antti Mäkitie; Leif Bäck; Risto Ko 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 168 KB 👁 2 views

## Abstract Fresh‐frozen biopsies were obtained from 61 patients at diagnosis of squamous cell carcinoma of the head and neck (HNSCC) for study of the prevalence and physical status of human papillomavirus (HPV) DNA. The frequency of HPV DNA and genotypes were determined by SPF10 PCR screening with

High-risk human papillomavirus in oral s
✍ Estela Kaminagakura; Luísa Lina Villa; Maria Antonieta Andreoli; João Simão Sobr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 988 KB

## Abstract The aim of this study was to investigate a possible relation between oral squamous cell carcinoma (SCC), the presence of high‐risk human papillomavirus (HR‐HPV) DNA and p16 expression in young patients. Paraffin‐embedded tumor blocks from 47 oral SCC of young (≤40‐year old) patients wer

Efficacy of neck treatment in patients w
✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

Impact of comorbidity on outcome of youn
✍ Bhuvanesh Singh; Mahesh Bhaya; Marc Zimbler; Jordan Stern; J. Thomas Roland; Ric 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 3 views

Background. Comorbid conditions have a significant impact on the actuarial survival of patients with head and neck cancer. However, no studies have evaluated the impact of comorbidity on tumor-and treatment-specific outcomes. This study was performed to evaluate the impact of comorbidity, graded by